An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
Robert Lambkin-WilliamsColin GelderRichard BroughtonCorey P MallettAnthony S GilbertAlex MannDavid HeJohn S OxfordDavid BurtPublished in: PloS one (2016)
ClinicalTrials.gov NCT02522754.